333 related articles for article (PubMed ID: 26068030)
1. Mesenchymal Stem Cell Therapy for Autoimmune Disease: Risks and Rewards.
Munir H; McGettrick HM
Stem Cells Dev; 2015 Sep; 24(18):2091-100. PubMed ID: 26068030
[TBL] [Abstract][Full Text] [Related]
2. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
Front Immunol; 2021; 12():643170. PubMed ID: 33732263
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies.
Lopez-Santalla M; Bueren JA; Garin MI
EBioMedicine; 2021 Jul; 69():103427. PubMed ID: 34161884
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis.
Sarsenova M; Issabekova A; Abisheva S; Rutskaya-Moroshan K; Ogay V; Saparov A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769021
[TBL] [Abstract][Full Text] [Related]
5. Autologous hematopoietic stem cell transplantation in autoimmune diseases.
Annaloro C; Onida F; Lambertenghi Deliliers G
Expert Rev Hematol; 2009 Dec; 2(6):699-715. PubMed ID: 21082959
[TBL] [Abstract][Full Text] [Related]
6. Recent Developments in Clinical Applications of Mesenchymal Stem Cells in the Treatment of Rheumatoid Arthritis and Osteoarthritis.
Hwang JJ; Rim YA; Nam Y; Ju JH
Front Immunol; 2021; 12():631291. PubMed ID: 33763076
[TBL] [Abstract][Full Text] [Related]
7. [Mesenchymal stem cell treatment in autoimmune diseases].
Keyßer G
Z Rheumatol; 2020 Jun; 79(5):437-445. PubMed ID: 32322976
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of mesenchymal stem cells on systemic lupus erythematosus:a meta-analysis].
Liu S; Guo YL; Yang JY; Wang W; Xu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1014-1021. PubMed ID: 30562774
[TBL] [Abstract][Full Text] [Related]
9. The immunomodulatory effects of mesenchymal stromal cell-based therapy in human and animal models of systemic lupus erythematosus.
Radmanesh F; Mahmoudi M; Yazdanpanah E; Keyvani V; Kia N; Nikpoor AR; Zafari P; Esmaeili SA
IUBMB Life; 2020 Nov; 72(11):2366-2381. PubMed ID: 33006813
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus.
Li A; Guo F; Pan Q; Chen S; Chen J; Liu HF; Pan Q
Front Immunol; 2021; 12():728190. PubMed ID: 34659214
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis.
Papadopoulou A; Yiangou M; Athanasiou E; Zogas N; Kaloyannidis P; Batsis I; Fassas A; Anagnostopoulos A; Yannaki E
Ann Rheum Dis; 2012 Oct; 71(10):1733-40. PubMed ID: 22586171
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells: ideal seeds for treating diseases.
Gao G; Fan C; Li W; Liang R; Wei C; Chen X; Yang Y; Zhong Y; Shao Y; Kong Y; Li Z; Zhu X
Hum Cell; 2021 Nov; 34(6):1585-1600. PubMed ID: 34272720
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem/Stromal Cell-Based Therapies in Systemic Rheumatic Disease: From Challenges to New Approaches for Overcoming Restrictions.
Lee BW; Kwok SK
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373308
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stromal cells and rheumatic disorders.
Tyndall A
Immunol Lett; 2015 Dec; 168(2):201-7. PubMed ID: 26142543
[TBL] [Abstract][Full Text] [Related]
15. [Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases?].
Larghero J; Vija L; Lecourt S; Michel L; Verrecchia F; Farge D
Rev Med Interne; 2009 Mar; 30(3):287-99. PubMed ID: 18930338
[TBL] [Abstract][Full Text] [Related]
16. Advances in mesenchymal stromal cell therapy in the management of Crohn's disease.
Ibraheim H; Giacomini C; Kassam Z; Dazzi F; Powell N
Expert Rev Gastroenterol Hepatol; 2018 Feb; 12(2):141-153. PubMed ID: 29096549
[TBL] [Abstract][Full Text] [Related]
17. Safety and immune regulatory properties of canine induced pluripotent stem cell-derived mesenchymal stem cells.
Chow L; Johnson V; Regan D; Wheat W; Webb S; Koch P; Dow S
Stem Cell Res; 2017 Dec; 25():221-232. PubMed ID: 29172152
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal Stem/Stromal Cells for Rheumatoid Arthritis Treatment: An Update on Clinical Applications.
Lopez-Santalla M; Fernandez-Perez R; Garin MI
Cells; 2020 Aug; 9(8):. PubMed ID: 32784608
[TBL] [Abstract][Full Text] [Related]
19. Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with Crohn's disease.
Taddio A; Tommasini A; Valencic E; Biagi E; Decorti G; De Iudicibus S; Cuzzoni E; Gaipa G; Badolato R; Prandini A; Biondi A; Ventura A
World J Gastroenterol; 2015 Apr; 21(14):4379-84. PubMed ID: 25892890
[TBL] [Abstract][Full Text] [Related]
20. Serum IFN-γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients.
Wang D; Wang S; Huang S; Zhang Z; Yuan X; Feng X; Lu L; Sun L
Stem Cells Transl Med; 2017 Sep; 6(9):1777-1785. PubMed ID: 28755405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
